Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Inhibition of angiogenesis by the nutraceutical Terasen® in the chorioallantoic membrane from chicken embryo

Version 1 : Received: 30 September 2023 / Approved: 2 October 2023 / Online: 2 October 2023 (11:01:58 CEST)

How to cite: De Melo, E.L.; Tavares, B.A.M.; Santos, A.V.T.D.L.T.D.; Ferreira, A.M.; Carvalho, H.D.O.; Castro, A.N.; Pereira, A.C.M.; Moreira, L.F.; Carvalho, J.C.T. Inhibition of angiogenesis by the nutraceutical Terasen® in the chorioallantoic membrane from chicken embryo. Preprints 2023, 2023100051. https://doi.org/10.20944/preprints202310.0051.v1 De Melo, E.L.; Tavares, B.A.M.; Santos, A.V.T.D.L.T.D.; Ferreira, A.M.; Carvalho, H.D.O.; Castro, A.N.; Pereira, A.C.M.; Moreira, L.F.; Carvalho, J.C.T. Inhibition of angiogenesis by the nutraceutical Terasen® in the chorioallantoic membrane from chicken embryo. Preprints 2023, 2023100051. https://doi.org/10.20944/preprints202310.0051.v1

Abstract

Angiogenesis is a process whereby new blood vessels are born from preexistent ones, which has a role in transporting oxygen and nutrients. On the other hand, inhibiting this process is a strategy used to treat some diseases, including cancers, diabetic retinopathy, and rheumatoid arthritis. This study investigates the effect of a new nutraceutical (Terasen®) on angiogenesis. Terasen® is made from a standardized extract of Euterpe oleraceae (Açaí), Myrciaria dubia (Camu-Camu), and purified oil of Bixa orellana (Annatto) and Astrocaryum aculeatum (Tucumã). The in vivo angiogenesis model used was the chorioallantoic membrane (CAM) from chicken embryos. The embryos were divided into seven groups: a vehicle control treated with ethanol solution (ETH), a naïve control treated only with saline solution (SOR), a positive control treated with dexamethasone (DEX), and four groups treated with Terasen® at different concentrations (0.5, 1, 2, and 3 mg/ml). The parameters assessed were the vessels’ area, length, and amount. The results show a statistically significant and concentration-dependent inhibition of angiogenesis caused by Terasen®. Our results suggest the nutraceutical has a high antiangiogenesis potential, possibly due to its bioactive compounds, including anthocyanins, quercetin, and tocotrienols.

Keywords

angiogenesis; nutraceuticals; chorioallantoic membrane; anthocyanins; tocotrienols.

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.